Exact Sciences, which is headquartered in the UW Research Park and has labs along the Beltline on Madison’s West Side, has announced that its Oncodetect molecular residual disease test has received approval through the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program.
Office of Strategic Communication